CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2008-03-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −754 | $3.74 | $3K | 41,840 |
| 2008-03-05 | Kessler Paul D. SVP Clinical, Med. & Reg.; CMO | Sale | −600 | $3.74 | $2K | 41,240 |
| 2008-03-05 | FAHIM RAAFAT E F President and CEO | Sale | −2,100 | $3.75 | $8K | 127,567.27 |
| 2008-03-05 | FAHIM RAAFAT E F President and CEO | Sale | −1,825 | $3.75 | $7K | 125,742.27 |
| 2008-03-05 | FAHIM RAAFAT E F President and CEO | Sale | −2,725 | $3.76 | $10K | 123,017.27 |
| 2008-03-05 | FAHIM RAAFAT E F President and CEO | Sale | −250 | $3.77 | $943 | 122,767.27 |
| 2008-03-05 | FAHIM RAAFAT E F President and CEO | Sale | −200 | $3.77 | $754 | 122,567.27 |
| 2008-03-05 | FAHIM RAAFAT E F President and CEO | Sale | −400 | $3.78 | $2K | 122,167.27 |
| 2008-03-05 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −2,100 | $3.80 | $8K | 91,057.19 |
| 2008-03-05 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −3,200 | $3.80 | $12K | 87,857.19 |
| 2008-03-05 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −300 | $3.78 | $1K | 87,557.19 |
| 2008-03-05 | Siegel Jordan I Sr. VP Fin. & Admin, CFO Treas | Sale | −1,900 | $3.80 | $7K | 85,657.19 |
| 2008-01-22 | FAHIM RAAFAT E F President and CEO | Grant or award | +50,000 | 176,730.42 | ||
| 2008-01-22 | FAHIM RAAFAT E F President and CEO | Grant or award | +7,000 | 183,730.42 | ||
| 2007-10-15 | Hudson Leslie Interim President & CEO | Grant or award | +20,000 | 31,759 | ||
| 2007-10-15 | Hudson Leslie Interim President & CEO | Grant or award | +48,000 | 79,759 | ||
| 2007-08-15 | Hudson Leslie Interim President & CEO | Returned to the company | −1,307 | 11,759 | ||
| 2007-05-18 | SUDOVAR STEPHEN Director | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2007-05-18 | Siegel Jordan I Sr. VP, Fin., CFO and Treas. | Grant or award | +30,000 | 90,000 | ||
| 2007-05-18 | Siegel Jordan I Sr. VP, Fin., CFO and Treas. | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 |
Page 38 of 42 · 830 trades